Apotheek Els Verfaillie N.V. SA
Apotheek Els Verfaillie N.V. reported total assets of 466,926 € at the end of the 2024 financial year (annual accounts filed with the NBB on 24 Jun 2025).
The score of Apotheek Els Verfaillie N.V. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +1 % Total assets +5 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Els Verfaillie N.V.'s annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 24 Jun 2025
- Year ended 31 Dec 2023filed on 05 Jul 2024
- Year ended 31 Dec 2022filed on 23 Jun 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
- Year ended 31 Dec 2020filed on 25 Jun 2021
Apotheek Els Verfaillie N.V.'s financial analysis
- Solvency22.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Els Verfaillie N.V.
Apotheek Els Verfaillie N.V.'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0432.490.138
- VAT number
- BE0432490138
- Peppol
- Registered · 0208:0432490138 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 12 Nov 1987
- Registered office
- 1780 Wemmel
- Latest accounts
- 2024 · filed on 24 Jun 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Els Verfaillie N.V. (SA) has been based in Wemmel since 1987, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of — and equity of 104,314 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Els Verfaillie N.V.
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Florair Retail sale of pharmaceutical products Jette · balance sheet 473,805 €
- MV Pharma Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 469,186 €
- Vipharma Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 467,095 €
- Vancophar Retail sale of pharmaceutical products Bierbeek · balance sheet 466,628 €
- Bephar Retail sale of pharmaceutical products Frameries · balance sheet 466,425 €
- PharmaConseil Retail sale of pharmaceutical products Verviers · balance sheet 468,687 €
- Frencken Retail sale of pharmaceutical products Antwerp · balance sheet 464,818 €
- Jely Pharma Retail sale of pharmaceutical products Incourt · balance sheet 469,684 €
Frequently asked questions about Apotheek Els Verfaillie N.V.
What is the revenue of Apotheek Els Verfaillie N.V.?
Apotheek Els Verfaillie N.V. files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Apotheek Els Verfaillie N.V.?
In Belgium, the VAT number is the company number prefixed with BE: BE0432490138 for Apotheek Els Verfaillie N.V., if the company is VAT-registered. Its company number (CBE) is 0432.490.138.
Where is the registered office of Apotheek Els Verfaillie N.V.?
According to the CBE register, the registered office of Apotheek Els Verfaillie N.V. is in 1780 Wemmel.
What is the equity of Apotheek Els Verfaillie N.V.?
At the close of the 2024 financial year, the equity of Apotheek Els Verfaillie N.V. amounts to 104,314 €, a solvency of 22.3% of total assets.
Who manages Apotheek Els Verfaillie N.V.?
The register lists 3 active mandates at Apotheek Els Verfaillie N.V.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Els Verfaillie N.V.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →